Cargando…
Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019
Coronavirus disease 2019 (COVID‐19) is caused by a contagious virus that has spread to more than 200 countries, territories, and regions. Thousands of studies to date have examined all aspects of this disease, yet little is known about the postrecovery status of patients, especially in the long term...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250600/ https://www.ncbi.nlm.nih.gov/pubmed/33830538 http://dx.doi.org/10.1002/jmv.27002 |
_version_ | 1783717060591747072 |
---|---|
author | Ali, Kameran M. Ali, Ayad M. Tawfeeq, Hassan M. Figueredo, Grazziela P. Rostam, Hassan M. |
author_facet | Ali, Kameran M. Ali, Ayad M. Tawfeeq, Hassan M. Figueredo, Grazziela P. Rostam, Hassan M. |
author_sort | Ali, Kameran M. |
collection | PubMed |
description | Coronavirus disease 2019 (COVID‐19) is caused by a contagious virus that has spread to more than 200 countries, territories, and regions. Thousands of studies to date have examined all aspects of this disease, yet little is known about the postrecovery status of patients, especially in the long term. Here, we examined erythrocyte sedimentation rate (ESR), C‐reactive protein (CRP), and serum albumin biomarkers in patients with a history of severe and mild‐to‐moderate COVID‐19 following their recovery. In patients with severe COVID‐19 serum albumin had a strong negative correlation with both ESR and CRP levels (R (2) = − 0.861 and R (2) = − 0.711), respectively. Also, there was a positive correlation between ESR and CRP level (R (2) = 0.85) in the same group. However, there was no correlation between these biomarkers among mild‐to‐moderate COVID‐19 patients. In addition, no correlation was recorded between the severe and mild‐to‐moderate COVID‐19 groups. This finding highlights the sustained elevation of ESR and CRP level and reduced serum albumin level that may persist postrecovery in patients with a history of severe COVID‐19. |
format | Online Article Text |
id | pubmed-8250600 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82506002021-07-02 Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019 Ali, Kameran M. Ali, Ayad M. Tawfeeq, Hassan M. Figueredo, Grazziela P. Rostam, Hassan M. J Med Virol Research Articles Coronavirus disease 2019 (COVID‐19) is caused by a contagious virus that has spread to more than 200 countries, territories, and regions. Thousands of studies to date have examined all aspects of this disease, yet little is known about the postrecovery status of patients, especially in the long term. Here, we examined erythrocyte sedimentation rate (ESR), C‐reactive protein (CRP), and serum albumin biomarkers in patients with a history of severe and mild‐to‐moderate COVID‐19 following their recovery. In patients with severe COVID‐19 serum albumin had a strong negative correlation with both ESR and CRP levels (R (2) = − 0.861 and R (2) = − 0.711), respectively. Also, there was a positive correlation between ESR and CRP level (R (2) = 0.85) in the same group. However, there was no correlation between these biomarkers among mild‐to‐moderate COVID‐19 patients. In addition, no correlation was recorded between the severe and mild‐to‐moderate COVID‐19 groups. This finding highlights the sustained elevation of ESR and CRP level and reduced serum albumin level that may persist postrecovery in patients with a history of severe COVID‐19. John Wiley and Sons Inc. 2021-05-03 2021-07 /pmc/articles/PMC8250600/ /pubmed/33830538 http://dx.doi.org/10.1002/jmv.27002 Text en © 2021 The Authors. Journal of Medical Virology Published by Wiley Periodicals LLC https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Ali, Kameran M. Ali, Ayad M. Tawfeeq, Hassan M. Figueredo, Grazziela P. Rostam, Hassan M. Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019 |
title | Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019 |
title_full | Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019 |
title_fullStr | Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019 |
title_full_unstemmed | Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019 |
title_short | Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019 |
title_sort | hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019 |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250600/ https://www.ncbi.nlm.nih.gov/pubmed/33830538 http://dx.doi.org/10.1002/jmv.27002 |
work_keys_str_mv | AT alikameranm hypoalbuminemiainpatientsfollowingtheirrecoveryfromseverecoronavirusdisease2019 AT aliayadm hypoalbuminemiainpatientsfollowingtheirrecoveryfromseverecoronavirusdisease2019 AT tawfeeqhassanm hypoalbuminemiainpatientsfollowingtheirrecoveryfromseverecoronavirusdisease2019 AT figueredograzzielap hypoalbuminemiainpatientsfollowingtheirrecoveryfromseverecoronavirusdisease2019 AT rostamhassanm hypoalbuminemiainpatientsfollowingtheirrecoveryfromseverecoronavirusdisease2019 |